Frost & Sullivan Recognizes BostonGene with Frost & Sullivan’s Enabling Technology Leadership Award for Revolutionizing Precision Oncology Diagnostics
BostonGene, a leading provider of molecular and immune profiling solutions, has been awarded the 2024 Frost & Sullivan Enabling Technology Leadership Award .
- BostonGene, a leading provider of molecular and immune profiling solutions, has been awarded the 2024 Frost & Sullivan Enabling Technology Leadership Award .
- The analyst firm uses a rigorous analytical process to evaluate nominees before determining the award recipient.
- “Frost & Sullivan recognizes that BostonGene is at the forefront of oncological innovation, exemplified by its groundbreaking progress in next-generation sequencing, digital image analysis, and immunoprofiling,” said Natalia Casanovas, Best Practices Research Analyst at Frost & Sullivan.
- BostonGene is reshaping the landscape of precision medicine by strategically focusing on novel research and impactful solutions, expanding personalized medicine beyond the limits of oncology.